Financial - Data & Stock Exchanges
Compare Stocks
4 / 10Stock Comparison
MCO vs ICE vs SPGI vs CME
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
MCO vs ICE vs SPGI vs CME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $80.02B | $88.26B | $124.36B | $102.04B |
| Revenue (TTM) | $7.72B | $12.64B | $15.34B | $6.52B |
| Net Income (TTM) | $2.50B | $3.30B | $4.78B | $4.24B |
| Gross Margin | 68.2% | 61.9% | 70.2% | 86.1% |
| Operating Margin | 44.8% | 38.7% | 42.2% | 64.9% |
| Forward P/E | 27.0x | 19.3x | 21.4x | 23.0x |
| Total Debt | $7.35B | $20.28B | $14.20B | $3.76B |
| Cash & Equiv. | $2.38B | $837M | $1.75B | $4.42B |
MCO vs ICE vs SPGI vs CME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Moody's Corporation (MCO) | 100 | 168.8 | +68.8% |
| Intercontinental Ex… (ICE) | 100 | 160.2 | +60.2% |
| S&P Global Inc. (SPGI) | 100 | 129.3 | +29.3% |
| CME Group Inc. (CME) | 100 | 154.0 | +54.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MCO vs ICE vs SPGI vs CME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MCO is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 8.9%, EPS growth 21.4%
- 403.4% 10Y total return vs CME's 279.0%
- 8.9% NII/revenue growth vs CME's 6.4%
ICE is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 14 yrs, beta 0.30, yield 1.2%
- Lower volatility, beta 0.30, Low D/E 69.9%, current ratio 1.02x
- Beta 0.30, yield 1.2%, current ratio 1.02x
- Lower P/E (19.3x vs 21.4x), PEG 2.18 vs 2.46
SPGI lags the leaders in this set but could rank higher in a more targeted comparison.
CME carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 1.68 vs MCO's 3.46
- Efficiency ratio 0.2% vs SPGI's 0.3% (lower = leaner)
- 3.9% yield, 6-year raise streak, vs MCO's 0.9%
- +3.7% vs SPGI's -16.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% NII/revenue growth vs CME's 6.4% | |
| Value | Lower P/E (19.3x vs 21.4x), PEG 2.18 vs 2.46 | |
| Quality / Margins | Efficiency ratio 0.2% vs SPGI's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.30 vs MCO's 0.82, lower leverage | |
| Dividends | 3.9% yield, 6-year raise streak, vs MCO's 0.9% | |
| Momentum (1Y) | +3.7% vs SPGI's -16.5% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs SPGI's 0.3% |
MCO vs ICE vs SPGI vs CME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MCO vs ICE vs SPGI vs CME — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 3 of 6 categories
ICE leads 1 • MCO leads 1 • SPGI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SPGI is the larger business by revenue, generating $15.3B annually — 2.4x CME's $6.5B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to ICE's 26.1%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $7.7B | $12.6B | $15.3B | $6.5B |
| EBITDAEarnings before interest/tax | $4.0B | $6.5B | $7.8B | $4.7B |
| Net IncomeAfter-tax profit | $2.5B | $3.3B | $4.8B | $4.2B |
| Free Cash FlowCash after capex | $3.0B | $4.3B | $5.6B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +68.2% | +61.9% | +70.2% | +86.1% |
| Operating MarginEBIT ÷ Revenue | +44.8% | +38.7% | +42.2% | +64.9% |
| Net MarginNet income ÷ Revenue | +31.9% | +26.1% | +29.2% | +62.0% |
| FCF MarginFCF ÷ Revenue | +33.4% | +33.9% | +35.6% | +64.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +7.8% | +23.1% | +32.5% | +21.4% |
Valuation Metrics
ICE leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 25.2x trailing earnings, CME trades at a 24% valuation discount to MCO's 33.0x P/E. Adjusting for growth (PEG ratio), CME offers better value at 1.84x vs MCO's 4.23x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $80.0B | $88.3B | $124.4B | $102.0B |
| Enterprise ValueMkt cap + debt − cash | $85.0B | $107.7B | $136.8B | $101.4B |
| Trailing P/EPrice ÷ TTM EPS | 33.02x | 27.01x | 28.66x | 25.20x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.02x | 19.34x | 21.40x | 22.98x |
| PEG RatioP/E ÷ EPS growth rate | 4.23x | 3.04x | 3.29x | 1.84x |
| EV / EBITDAEnterprise value multiple | 21.60x | 16.68x | 17.87x | 22.50x |
| Price / SalesMarket cap ÷ Revenue | 10.37x | 6.98x | 8.11x | 15.65x |
| Price / BookPrice ÷ Book value/share | 19.31x | 3.07x | 3.55x | 3.53x |
| Price / FCFMarket cap ÷ FCF | 31.08x | 20.58x | 22.79x | 24.33x |
Profitability & Efficiency
MCO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MCO delivers a 64.1% return on equity — every $100 of shareholder capital generates $64 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCO's 1.75x. On the Piotroski fundamental quality scale (0–9), MCO scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +64.1% | +11.6% | +12.9% | +15.3% |
| ROA (TTM)Return on assets | +16.2% | +2.3% | +7.9% | +2.2% |
| ROICReturn on invested capital | +22.5% | +7.5% | +9.7% | +10.2% |
| ROCEReturn on capital employed | +27.9% | +9.5% | +12.1% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 9 | 7 | 5 |
| Debt / EquityFinancial leverage | 1.75x | 0.70x | 0.39x | 0.13x |
| Net DebtTotal debt minus cash | $5.0B | $19.4B | $12.5B | -$666M |
| Cash & Equiv.Liquid assets | $2.4B | $837M | $1.7B | $4.4B |
| Total DebtShort + long-term debt | $7.4B | $20.3B | $14.2B | $3.8B |
| Interest CoverageEBIT ÷ Interest expense | 17.22x | 6.53x | 22.69x | 41.55x |
Total Returns (Dividends Reinvested)
CME leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CME five years ago would be worth $15,775 today (with dividends reinvested), compared to $11,215 for SPGI. Over the past 12 months, CME leads with a +3.7% total return vs SPGI's -16.5%. The 3-year compound annual growth rate (CAGR) favors CME at 19.0% vs SPGI's 6.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.3% | -2.3% | -17.9% | +7.1% |
| 1-Year ReturnPast 12 months | -3.5% | -10.6% | -16.5% | +3.7% |
| 3-Year ReturnCumulative with dividends | +51.0% | +50.5% | +21.4% | +68.4% |
| 5-Year ReturnCumulative with dividends | +40.1% | +43.7% | +12.2% | +57.8% |
| 10-Year ReturnCumulative with dividends | +403.4% | +224.7% | +328.9% | +279.0% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +14.6% | +6.7% | +19.0% |
Risk & Volatility
CME leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.32 beta — it tends to amplify market swings less than MCO's 0.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CME currently trades 85.4% from its 52-week high vs SPGI's 72.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.30x | 0.55x | -0.32x |
| 52-Week HighHighest price in past year | $546.88 | $189.35 | $579.05 | $329.16 |
| 52-Week LowLowest price in past year | $402.28 | $143.17 | $381.61 | $257.17 |
| % of 52W HighCurrent price vs 52-week peak | +82.5% | +82.3% | +72.6% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 45.4 | 47.6 | 42.2 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 3.0M | 1.8M | 2.2M |
Analyst Outlook
Evenly matched — MCO and CME each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MCO as "Buy", ICE as "Buy", SPGI as "Buy", CME as "Hold". Consensus price targets imply 30.5% upside for SPGI (target: $548) vs 13.9% for CME (target: $320). For income investors, CME offers the higher dividend yield at 3.88% vs MCO's 0.86%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $544.75 | $195.71 | $548.11 | $320.25 |
| # AnalystsCovering analysts | 32 | 36 | 28 | 35 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.2% | +0.9% | +3.9% |
| Dividend StreakConsecutive years of raises | 22 | 14 | 12 | 6 |
| Dividend / ShareAnnual DPS | $3.90 | $1.93 | $3.83 | $10.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +1.6% | +4.0% | +0.3% |
CME leads in 3 of 6 categories (Income & Cash Flow, Total Returns). ICE leads in 1 (Valuation Metrics). 1 tied.
MCO vs ICE vs SPGI vs CME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MCO or ICE or SPGI or CME a better buy right now?
For growth investors, Moody's Corporation (MCO) is the stronger pick with 8.
9% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 2x trailing P/E (23. 0x forward), making it the more compelling value choice. Analysts rate Moody's Corporation (MCO) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MCO or ICE or SPGI or CME?
On trailing P/E, CME Group Inc.
(CME) is the cheapest at 25. 2x versus Moody's Corporation at 33. 0x. On forward P/E, Intercontinental Exchange, Inc. is actually cheaper at 19. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CME Group Inc. wins at 1. 68x versus Moody's Corporation's 3. 46x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MCO or ICE or SPGI or CME?
Over the past 5 years, CME Group Inc.
(CME) delivered a total return of +57. 8%, compared to +12. 2% for S&P Global Inc. (SPGI). Over 10 years, the gap is even starker: MCO returned +403. 4% versus ICE's +224. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MCO or ICE or SPGI or CME?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 32β versus Moody's Corporation's 0. 82β — meaning MCO is approximately -358% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 175% for Moody's Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — MCO or ICE or SPGI or CME?
By revenue growth (latest reported year), Moody's Corporation (MCO) is pulling ahead at 8.
9% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Moody's Corporation grew EPS 21. 4% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MCO or ICE or SPGI or CME?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 26. 1% for Intercontinental Exchange, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 38. 7% for ICE. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MCO or ICE or SPGI or CME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CME Group Inc. (CME) is the more undervalued stock at a PEG of 1. 68x versus Moody's Corporation's 3. 46x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Intercontinental Exchange, Inc. (ICE) trades at 19. 3x forward P/E versus 27. 0x for Moody's Corporation — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPGI: 30. 5% to $548. 11.
08Which pays a better dividend — MCO or ICE or SPGI or CME?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 3. 9%, versus 0. 9% for Moody's Corporation (MCO).
09Is MCO or ICE or SPGI or CME better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 32), 3. 9% yield, +279. 0% 10Y return). Both have compounded well over 10 years (CME: +279. 0%, MCO: +403. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MCO and ICE and SPGI and CME?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MCO is a mid-cap quality compounder stock; ICE is a mid-cap quality compounder stock; SPGI is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.